Key Highlights
- Multi-year agreement to utilize Tablo Hemodialysis System in 33 states.
- Focus on patient autonomy: Tablo reduces dialysis complexity, boosting employment and daily activity control for patients.
- Technological advancement: Tablo allows dialysis anywhere with simple setup, transforming patient experience.
Source: Business Wire
Notable Quotes
- “Our collaboration… is an important step forward in providing dialysis patients with options for where, when and how they want to dialyze.” – Leslie Trigg, Chair and CEO at Outset Medical
- “We strive to provide patients with new and innovative solutions that deliver the best outcomes possible.” – Steve Nottingham, Co-Chief Operating Officer at U.S. Renal Care
SoHC's Take
This partnership marks a significant milestone in the treatment of end-stage kidney disease (ESKD). By leveraging Outset Medical’s Tablo, a system that simplifies and democratizes the dialysis process, U.S. Renal Care is positioned to radically enhance the quality of life for many patients. The move towards more accessible home hemodialysis underlines a shift in healthcare towards more patient-centered solutions that prioritize convenience, comfort, and control over one’s treatment schedule — essential for increasing patient engagement and overall well-being.
